Avrobio
(NASDAQ:AVRO)
$1.22
0[0.00%]
Last update: 5:02PM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
62.5%
Overview Rating
Good
Technicals Analysis
66
0100
Financials Analysis
60
0100

Avrobio Stock (NASDAQ:AVRO), Quotes and News Summary

Avrobio Stock (NASDAQ: AVRO) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.238.000 / 293.839K
Day Range- - -
52 Wk Range0.570 - 1.700
Market Cap$54.751M
P/E Ratio4.519
Dividend Yield-
ExchangeNASDAQ
RSI
38
Short Interest
0.36%
Days to Cover1

Recent News

Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.
Lisa Levin
Why Avrobio Shares Are Rising Wednesday
AVROBIO Inc (NASDAQ: AVRO) shares are trading higher Wednesday after the company said it will explore strategic alternatives.
Adam Eckert
Avrobio Stock Jumps On Sale Of Gene Therapy Program To Novartis
Shares of clinical-stage gene therapy company AVROBIO, Inc. (NASDAQ: AVRO) are trading higher Monday due to its agreement to sell its investigational hematopoietic stem cell (HSC) gene therapy program for the treatment of cystinosis
Ryan Gustafson
60%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Dec 23
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.2
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
About AvroBio Inc
Sector
Health Care
Industry
Biotechnology
Avrobio Inc is a clinical-stage gene therapy company. The company is engaged in developing potential...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
AVRO
KZR

FAQ

Q

How do I buy Avrobio (AVRO) stock?

A

You can purchase shares of Avrobio (NASDAQ: AVRO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Avrobio's (AVRO) competitors?

A

Other companies in Avrobio’s space includes: Kezar Life Sciences (NASDAQ:KZR), Vaxxinity (NASDAQ:VAXX), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS) and Eagle Pharmaceuticals (NASDAQ:EGRX).

Q

What is the target price for Avrobio (AVRO) stock?

A

The latest price target for Avrobio (NASDAQ: AVRO) was reported by Mizuho on Monday, December 18, 2023. The analyst firm set a price target for 2.00 expecting AVRO to rise to within 12 months (a possible 63.93% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Avrobio (AVRO)?

A

The stock price for Avrobio (NASDAQ: AVRO) is $1.22 last updated April 17, 2024 at 4:00 PM EDT.

Q

Does Avrobio (AVRO) pay a dividend?

A

There are no upcoming dividends for Avrobio.

Q

When is Avrobio (NASDAQ:AVRO) reporting earnings?

A

Avrobio’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Q

Is Avrobio (AVRO) going to split?

A

There is no upcoming split for Avrobio.

Q

What sector and industry does Avrobio (AVRO) operate in?

A

Avrobio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch